Titre
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Marinozzi, M. C.
Auteure/Auteur
Chauvet, S.
Auteure/Auteur
Le Quintrec, M.
Auteure/Auteur
Mignotet, M.
Auteure/Auteur
Petitprez, F.
Auteure/Auteur
Legendre, C.
Auteure/Auteur
Cailliez, M.
Auteure/Auteur
Deschenes, G.
Auteure/Auteur
Fischbach, M.
Auteure/Auteur
Karras, A.
Auteure/Auteur
Nobili, F.
Auteure/Auteur
Pietrement, C.
Auteure/Auteur
Dragon-Durey, M. A.
Auteure/Auteur
Fakhouri, F.
Auteure/Auteur
Roumenina, L. T.
Auteure/Auteur
Fremeaux-Bacchi, V.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1523-1755
Statut éditorial
Publié
Date de publication
2017-11
Volume
92
Numéro
5
Première page
1232
Dernière page/numéro d’article
1241
Langue
anglais
Notes
Marinozzi, Maria-Chiara
Chauvet, Sophie
Le Quintrec, Moglie
Mignotet, Morgane
Petitprez, Florent
Legendre, Christophe
Cailliez, Mathilde
Deschenes, Georges
Fischbach, Michel
Karras, Alexandre
Nobili, Francois
Pietrement, Christine
Dragon-Durey, Marie-Agnes
Fakhouri, Fadi
Roumenina, Lubka T
Fremeaux-Bacchi, Veronique
eng
Research Support, Non-U.S. Gov't
Kidney Int. 2017 Nov;92(5):1232-1241. doi: 10.1016/j.kint.2017.04.017. Epub 2017 Jul 14.
Chauvet, Sophie
Le Quintrec, Moglie
Mignotet, Morgane
Petitprez, Florent
Legendre, Christophe
Cailliez, Mathilde
Deschenes, Georges
Fischbach, Michel
Karras, Alexandre
Nobili, Francois
Pietrement, Christine
Dragon-Durey, Marie-Agnes
Fakhouri, Fadi
Roumenina, Lubka T
Fremeaux-Bacchi, Veronique
eng
Research Support, Non-U.S. Gov't
Kidney Int. 2017 Nov;92(5):1232-1241. doi: 10.1016/j.kint.2017.04.017. Epub 2017 Jul 14.
Résumé
C3 Glomerulopathies, which include Dense Deposit Disease and C3 Glomerulonephritis, are associated with genetic and acquired dysregulation of the C3 convertase alternative pathway of complement. The potential role of the activation of the C5 convertase has not been studied extensively. Here we analyzed IgG samples from patients with C3 Glomerulopathies to identify circulating autoantibodies that stabilize the C3 alternative pathway (C3 Nephritic Factors) as well as C5 convertases (C5 Nephritic Factors), thus preventing decay of these enzyme complexes. Rare variants in alternative pathway genes were found in 28 of 120 tested patients. C3 and C5 Nephritic Factors were found in 76 of 101 (75%) and 29 of 59 (49%) of the patients, respectively. Therefore, we compared the results of the assays for the C3 and C5 nephritic factors functional activity: 29% were positive for C3 Nephritic Factors alone, 39% were positive for both C3 and C5 Nephritic Factors, and 10% were positive for C5 Nephritic Factors alone. We found that the addition of properdin-enhanced stabilization of C3 convertase in the presence of IgG doubly positive for both Nephritic Factors, while it did not modify the stabilization mediated by IgG solely positive for C3 Nephritic Factors. Both C3 and C5 Nephritic Factors correlated with C3 consumption, while only C5 Nephritic Factors correlated with sC5b9 levels. C5 Nephritic Factors-positive patients were more likely to have C3 Glomerulonephritis than Dense Deposit Disease. Thus, dysregulation of the C5 convertase contributes to C3 Glomerulopathies inter-disease differences and may have direct therapeutic implications.
Sujets
PID Serval
serval:BIB_A3CE4A723109
PMID
Date de création
2022-03-01T09:18:02.036Z
Date de création dans IRIS
2025-05-21T04:50:24Z